Search for: "Mylan, Inc."
Results 461 - 480
of 587
Sorted by Relevance
|
Sort by Date
14 May 2015, 4:00 am
In Eli Lilly Canada Inc. v. [read post]
30 Apr 2015, 1:11 pm
A couple of days ago, we watched the lovely “St. [read post]
28 Mar 2014, 5:33 pm
Procedural History"Defendants-Appellants Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and Mylan Pharmaceuticals, Inc. [read post]
27 Jun 2011, 8:41 am
Amicus brief of Mylan Pharmaceuticals, Inc. [read post]
18 Feb 2020, 4:00 am
Pfizer Canada ULC, 2020 FC 1, at para. 42. [3] See Sections 27(3)(b) and 28.3 of the Patent Act, RSC 1985, c P-4 [4] Burton Parsons Chemicals, Inc v Hewlett-Packard (Canada) Ltd, [1976] 1 SCR 555 at 563 [5] Apotex Inc v Sanofi-Synthelabo Canada Inc, 2008 SCC 61 at paragraph 37, [2008] 3 SCR 265; see also Bell Helicopter Textron Canada Limitée v Eurocopter, société par actions simplifiée, 2013 FCA 219 at paragraph 65; Mylan… [read post]
18 Jul 2014, 11:55 am
Wyeth, Inc., 85 Cal. [read post]
28 Jun 2016, 6:41 am
MacroSolve, Inc., No. 15-1369 (district court’s too-high burden) Globus Medical, Inc. v. [read post]
9 Sep 2009, 7:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: CAFC debates whether claim term ‘animal’ includes humans: Martek Biosciences Corp v Nutrinova, Inc (Gray on Claims) (Patently-O) (Patently-O) (IP Watchdog) General USPTO-Pfizer workshop on IP & innovation in Mumbai (Intellectual Property Watch) Australia: Full Federal Court unanimously… [read post]
31 Aug 2010, 10:01 pm
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
12 Oct 2011, 12:33 pm
In addition, the Court denied a petition for certiorari brought by generic drug manufacturer Mylan Laboratories, Inc. [read post]
17 Mar 2015, 9:33 am
Mylan Inc., 761 F.3d 1042, 1045 (9th Cir. 2014). [read post]
21 Mar 2012, 11:32 am
The ruling, which was a victory for Mylan Inc.'s UDL Laboratories, Actavis Inc., and Teva Pharmaceutical Industries Ltd. by a 5-4 vote, overturned appeals court decisions that allowed for such complaints. [read post]
8 Oct 2009, 6:05 am
Teva, Mylan, Dr. [read post]
7 Sep 2011, 4:22 am
Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog) Please join the… [read post]
17 Oct 2013, 5:00 am
Medtronic, Inc., 238 F. [read post]
6 Nov 2014, 5:00 am
Mylan, Inc., 661 F. [read post]
10 Sep 2018, 10:17 am
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
1 Nov 2017, 2:58 pm
See, GE’s brief, for example, 16-712 bsac General Electric Company; also, 16-712 bsac BSA The Software Alliance; 16-712 bsac Unified Patents Inc.; and 16-712 bsac SAP America, Inc., et al. [read post]
26 Dec 2017, 7:08 pm
Mylan paid approximately $231.7 million to the federal government and $213.9 million to state Medicaid programs. [read post]
